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A B S T R A C T
Background: Door-to-balloon time (DBT) has become a measure of performance and is the focus in quality 
of care improvement initiatives. This study aimed to evaluate the association between DBT and its impact 
on hospital costs.
Methods: Patients treated with primary percutaneous coronary intervention between 2008 and 2013 were 
divided according to the DBT < or ≥ 90 minutes. All costs recorded at hospital discharge were adjusted by 
the Medical-Hospital Cost Variation Index. 
Results: A total of 141 patients were included, grouped as DBT < 90 minutes (n = 77) and DBT ≥ 90 minutes 
(n = 64). DBT was 64.0 ± 14.1 minutes and 133.8 ± 35.2 minutes, respectively. There were no differences 
in clinical outcomes between the groups. The costs were R$ 34,883.24 ± 27,749.46, with the mean cost 
for DBT < 90 minutes being R$ 33,194.24 ± 27,387.61 and the cost for DBT ≥ 90 minutes R$ 36,947.58 ± 
28,267.80 (p = 0.43). The costs, according to the culprit artery, were R$ 29,588.53 ± 16,358.85 for the right 
coronary artery; R$ 48,494.62 ± 44,015.04 for the left circumflex artery; and R$ 34,016.96 ± 26,503.94 for 
the left anterior descending artery. There was a difference between the costs of procedures related to the 
left circumflex artery when compared to the right coronary or left anterior descending arteries (p = 0.01), 
but there was no difference between the costs related to the right coronary, when compared to the left 
anterior descending artery (p = 0.68).
Conclusions: There was no difference in hospital costs regarding the private health insurance, when the 
groups were divided according to the DBT. Clinical outcomes were similar and a difference in costs was 
found for patients with the circumflex artery as the culprit vessel.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Há relação entre custos hospitalares e tempo porta-balão?
R E S U M O
Introdução: O tempo porta-balão (TPB) tornou-se uma medida de desempenho e é foco de iniciativas de 
melhoria da qualidade assistencial. Este estudo teve como objetivo avaliar a relação entre o TPB e seu 
impacto nos custos de internação hospitalar. 
Métodos: Pacientes tratados com intervenção coronária percutânea primária, entre 2008 e 2013, foram 
divididos de acordo com o TPB < ou ≥ 90 minutos. Todos os custos registrados na alta hospitalar foram 
ajustados por meio do Índice de Variação de Custos Médico-Hospitalares. 
Resultados: Foram incluídos 141 pacientes, agrupados em TPB < 90 minutos (n = 77) e TPB ≥ 90 minutos 
(n = 64). Os TPB foram 64,0 ± 14,1 minutos e 133,8 ± 35,2 minutos, respectivamente. Não foram observadas 
diferenças nos desfechos clínicos entre os grupos. Os custos foram de R$ 34.883,24 ± 27.749,46, sendo o 
custo médio para TPB < 90 minutos de R$ 33.194,24 ± 27.387,61, e para TPB ≥ 90 minutos, de R$ 36.947,58 
± 28.267,80 (p = 0,43). Os custos, segundo a artéria culpada, foram de R$ 29.588,53 ± 16.358,85 para a 
coronária direita; R$ 48.494,62 ± 44.015,04 para a circunflexa; e de R$ 34.016,96 ± 26.503,94 para 
a descendente anterior. Houve diferença entre os custos dos procedimentos relativos à artéria circunflexa 
comparados aos da coronária direita ou da descendente anterior (p = 0,01), mas não houve diferença entre 
os custos relativos à coronária direita, comparados à descendente anterior (p = 0,68). 
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Conclusões: Não houve diferença nos custos hospitalares, no âmbito da saúde suplementar, quando os 
grupos foram divididos de acordo com o TPB. Os desfechos clínicos foram semelhantes, e foi encontrada 
uma diferença de custos em pacientes com a artéria circunflexa culpada.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Door-to-balloon time (DBT) is one of the markers of quality of 
care and, according to the current guidelines, it should be less than 
90 minutes.1-3 Several clinical and logistic factors may be related to a 
high DBT.4-6 A decrease in DBT results in a reduction of short- and 
medium-term mortality, as well as lenght of hospital stay.7,8
In recent years, health care costs have increased faster than the 
general inflation rate, thus becoming a liability to be paid by both 
the institution that provides the service and the agents that finance 
the procedures. Cost control without loss of quality is, thus, an ur-
gent topic.9
Despite the positive effect of reducing DBT on patient outcomes, 
the impact on care-related costs in Brazil is still scarcely studied. As 
it represents a disease with high prevalence and of great influence in 
economic terms, as well as having significant morbidity and morta-
lity,10 it becomes essential to understand the costs associated with 
the management of patients with ST-elevation acute myocardial in-
farction (STEMI). 
This study aimed to evaluate the association between DBT and its 
impact on hospital costs.
Methods
Study place, design, and institutional measures 
In 2007, Hospital Vera Cruz, a tertiary hospital that integrates the 
supplementary health network in Belo Horizonte (MG), initiated a 
project on the quality of care provided to patients with acute myo-
cardial infarction through the measurement of several indicators, 
among them the DBT.
With the implementation of these indicators, measures were 
taken to improve the DBT, such as expedite the admission of pa-
tients in the emergency room; perform the 12-lead electrocardio-
gram (ECG) within 10 minutes after admission; and engaging the 
whole team, consisting of nurses and physicians (clinical and in-
terventional cardiologists) through a standardized code. With the 
implementation of these measures, there was a progressive re-
duction in DBT.
As determined by the quality program, epidemiological data and 
time related to treatment were collected and stored in an institution 
database. 
Study population
Between March 2008 and June 2013, 200 patients underwent pri-
mary percutaneous coronary intervention (pPCI). Patients transfer-
red from other institutions; those who developed STEMI after 
admission; those on prolonged cardiorespiratory arrest in the emer-
gency room; those with segment ST-elevation without evidence of 
coronary artery disease (e.g., acute myocarditis, ventricular repola-
rization disorder, or Takotsubo syndrome); and those submitted to 
staged treatment during the same hospital admission were excluded 
from the analysis.
The care was carried out following the on-duty schedule of the 
interventional cardiology laboratory, which has in-attendance and 
on-call medical and nursing staff 24 hours a day, 7 days a week.
The patients included in the study were divided into two groups 
according to DBT < or ≥ 90-minutes.
Procedure
Patients received a loading dose of 300 mg of acetylsalicylic 
acid and 300 to 600 mg of clopidogrel. The use of morphine, su-
blingual/intravenous nitrate, or beta-blocker was made at the 
discretion of the physician. All patients received unfractionated 
heparin immediately before the intervention (60 to 100 U/kg). 
Patients were taken to undergo the intervention as soon as the 
cath lab was available. The pPCI procedures were performed as 
described in literature.11 Specific technical aspects, such as ac-
cess route, drug administration, type of stent, and thromboaspi-
ration, were carried out at the discretion of the interventionists. 
After pPCI, patients were referred to the coronary care unit and 
received treatment according to the institutional protocol esta-
blished for STEMI.
Data collection
Data collection was performed in two ways. First, delays and epi-
demiological data were collected dating to the patient's admission at 
the institution; second, the data related to costs were collected 
through the review of medical records and of the invoices sent by 
the institution to the health insurance companies. This registry was 
approved by the Research Ethics Committee of the hospital 
(CAE 46658215.5.0000.5135).
Angiographic analysis and definitions
Lesion morphology was classif ied according to the defini-
tions established by the American College of Cardiology/Ameri-
can Heart Association (ACC/AHA).12 Angiographic analysis was 
performed by two of the authors (RW and MABE), identifying 
the culprit artery and considering as a significant lesion that 
which would cause vessel lumen obstruction > 70% by the visual 
method interpretation. Thrombus on the angiography was de-
fined as abrupt cessation of vessel f low, with contrast retention 
or a filling defect in a patent vessel (negative image) over a ste-
notic or adjacent region.13
Procedure success was defined as obtaining angiographic success 
(residual stenosis < 30% with Thrombolysis In Myocardial Infarction 
- TIMI grade 3 flow), as well as absence of major adverse cardiovas-
cular and cerebrovascular events, including death, reinfarction and 
emergency coronary artery bypass graft surgery.
The DBT was defined as the delay between the first medical 
contact and the first balloon inflation; total ischemic time was 
def ined as the delay between symptom onset and the f irst 
balloon inflation.
Lenght of hospital stay was recorded in days since the admission 
day (day zero). The analysis of the length of stay considered only the 
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patients who were discharged home, excluding those who died du-
ring the hospitalization period. 
Cost analysis
Hospital costs were described in Brazilian currency (Real). As 
they were recorded at the time of hospital discharge, all costs inclu-
ded in the analysis were adjusted by the Índice de Variação de Custos 
Médico-Hospitalares (VCMH/IESS).14 The costs referred to values 
charged by the institution from the supplementary health insurance 
companies, which included costs related to health care, procedures, 
medications, orthotics, and prosthetics, as well as to the daily cost of 
the intensive care unit.
All patients remain hospitalized at the discretion of the attending 
cardiologist, according to daily clinical practice.
Statistical analysis 
The collected data were stored in an Excel spreadsheet (Microsoft 
Corporation, Redmond, USA) and data analysis was carried out with 
the Statistical Package for the Social Sciences (SPSS) software, ver-
sion 9.0 (Chicago, USA). The qualitative variables are shown as abso-
lute number and frequency, and were analyzed by Chi-square or 
Fisher's exact test. Quantitative variables are shown as mean and 
standard deviation and were analyzed using Student’s t-test. All re-
sults were considered significant at p ≤ 0.05.
Results
Patients selected for final analysis (Fig. 1) were grouped into DBT 
< 90 minutes (n = 77) and DBT ≥ 90 minutes (n = 64). The mean 
DBT was 64.0 ± 14.1 minutes and 133.8 ± 35.2 minutes, respecti-
vely. No significant differences were observed regarding the clini-
cal variables (Table 1).
pPCI was carried out through the femoral access in 139 cases 
(98.5%), while the radial access was used in the remaining patients. 
The culprit artery in 50% of the cases was the left anterior descen-
ding (LAD) artery. A glycoprotein IIb/IIIa inhibitor was administered 
to 54.5% of patients in the group DBT < 90 minutes and to 56.4% of 
the patients in the group DBT ≥ 90 minutes (p = 0.88). A total of 151 
coronary stents were implanted, all bare-metal stents, with a mean 
of 1.1 ± 0.6 stents per patient.
No-reflow occurred in 4% of the patients in the group DBT < 90 
minutes and in 7.7% of the group DBT ≥ 90 minutes (p = 0.33) (Table 2).
There was no significant difference in the mean length of stay or 
the clinical outcomes between the groups (Table 3).
The overall mean costs of the procedures was R$ 34,883.24 ± 
27,749.46, with the mean cost for DBT < 90 minutes of R$ 33,194.24 ± 
27,387.61 and for DBT ≥ 90 minutes of R$ 36,947.58 ± 28,267.80 
(p = 0.43). The mean cost according to the affected artery was 
R$ 29,588.53 ± 16,358.85 for the right coronary artery (RCA), R$ 
48,494.62 ± 44,015.04 for the left circumflex artery (LCx) and 
R$ 34,016.96 ± 26,503.94 for the LAD. There was a significant diffe-
Figure 1. Flow chart of the selection of participants for the study. STEMI: ST-elevation acute myocardial infarction; pPCI: primary percutaneous coronary intervention.
Patients treated with 
STEMI diagnosis
n = 200
179 patients were submitted to pPCI
 38 patients with staged  
treatment during the same 
hospital stay (19%)
Final sample of 141 patients 
(70.5%)
21 patients excluded from the 
analysis (10.5%)
Transferred patients
Admitted patients
Prolonged cardiorespiratory arrest
Patients with ST-segment elevation 
with no evidence of coronary artery 
disease
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Table 1
Clinical characteristics.
Characteristics DBT < 90 minutes
(n = 77)
DBT ≥ 90 minutes
(n = 64)
p-value
Age, years 60.4 ± 12.9 65.1 ± 13.4 0.04
Male gender, n (%) 24 (31.2) 26 (40.6) 0.16
Diabetes mellitus, n (%) 15 (19.5) 16 (25.1) 0.28
Dyslipidemia, n (%) 29 (37.7) 26 (40.6) 0.43
Smoking, n (%) 30 (39.1) 19 (29.7) 0.32
Arterial hypertension, n (%) 44 (57.1) 43 (67.2) 0.15
Chronic renal failure, n (%) 5 (6.5) 4 (6.3) 0.62
Family history of CAD, n (%) 16 (20.8) 12 (18.8) 0.46
Sedentary life style, n (%) 29 (37.7) 22 (34.4) 0.41
Previous PCI, n (%) 10 (13.1) 10 (15.6) 0.42
Previous CABG, n (%) 1 (1.3) 4 (6.3) 0.12
Door-to-balloon time, minutes 65.0 ± 15.4 125.0 ± 33.9 < 0.01
Total ischemic time, minutes 248.9 ± 168.5 386.0 ± 179.9 < 0.01
Length of hospital stay, days 9.4 ± 9.7 8.4 ± 6.6 0.54
Killip-Kimball classification, n (%) 0.59
I 62 (80.5) 47 (73.4)
II 3 (3.9) 3 (4.7)
III/IV 12 (15.6) 14 (21.9)
LVEF, % 43.3 ± 25.8 48.6 ± 23.9 0.21
Hemoglobin, g/dL 13.3 ± 1.4 12.9 ± 1.6 0.14
DBT: door-to-balloon time; CAD: coronary artery disease; PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting; LVEF: left ventricular ejection fraction.
Table 2
Angiographic and procedure characteristics.
Characteristics DBT < 90 minutes
(n = 77)
DBT ≥ 90 minutes
(n = 64)
p-value
Number of affected vessels, n (%) 0.02
1 36 (46.8) 21 (32.8)
2 30 (39) 21 (32.8)
3 11 (14.3) 22 (34.4)
Culprit artery, n (%) 0.36
Left anterior descending artery 40 (51.9) 33 (51.6)
Left circumflex artery 14 (18.2) 9 (14.0)
Right coronary 23 (29.9) 18 (28.1)
LMCA 0 1 (1.6)
Saphenous vein graft 0 3 (4.7)
Use of glycoprotein IIb/IIIa, n (%) 71.4 (55) 44 (68.8) 0.88
Thrombus aspiration, n (%) 29 (37.7) 10 (15.6) 0.01
Stent diameter, mm 2.7 ± 1.2 3.0 ± 1.1 0.19
Stent length, mm 17.6 ± 8.9 16.1 ± 7.8 0.29
Pre TIMI flow, n (%) 0.39
0 53 (68.8) 44 (68.8)
1 12 (15.6) 5 (7.8)
2 4 (5.2) 6 (9.4)
3 8 (10.4) 9 (14.1)
Post TIMI flow, n (%) 0.73
0 3 (3.9) 2 (3.1)
1 4 (5.2) 4 (6.3)
2 2 (2.6) 4 (6.3)
3 68 (88.3) 54 (84.4)
No-reflow, n (%) 4 (5.2) 6 (9.4) 0.26
DBT: door-to-balloon time; LMCA, left main coronary artery; TIMI: Thrombolysis in Myocardial Infarction.
rence between the costs of the procedures related to the LCx when 
compared to the RCA (p = 0.01) or the LAD (p = 0.01), but there was 
no significant difference between the costs of the procedures for the 
RCA when compared to the LAD (p = 0.68).
Discussion
This study showed no difference regarding hospital costs in a pri-
vate hospital when the analyzed groups were divided regarding the 
DBT. The groups were similar considering clinical outcomes, with a 
difference found regarding costs in patients with a culprit artery in 
the LCx territory.
Hospital costs verified in this analysis are consistent with those re-
ported by national and international literature.15-18 The increase in heal-
th care costs is currently approximately two times higher than the 
annual economic growth of developed countries.19,20 In Brazil, the 
VCMH/IESS has also been higher than the National Broad Consumer 
Price Index (IPCA) since 2007. Since 2012, while the VCMH/IESS rose 
15.4%, inflation in the same period was 5.4% as measured by the IPCA.15
In a systematic review, we found only one study that evaluated 
the costs of implementing a quality program specifically designed to 
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Table 3
In-hospital clinical evolution.
Outcomes DBT < 90 minutes
(n = 77)
DBT ≥ 90 minutes
(n = 64)
p-value
Death, n (%) 5 (6.5) 4 (6.3) 0.61
Reinfarction, n (%) 1 (1.3) 0 0.54
Target vessel revascularization, n (%) 6 (7.8) 3 (4.7) 0.52
Stent thrombosis, n (%) 4 (5.2) 1 (1.6) 0.28
Cardiogenic shock , n (%) 3 (3.9) 5 (7.8) 0.26
Blood transfusion, n (%) 3 (3.9) 1 (1.6) 0.38
Infection, n (%) 7 (9.1) 9 (14.1) 0.25
DBT: door-to-balloon time.
improve the care of patients with STEMI, which showed a reduction 
in costs with improved DBT.21 In the present study, there was a re-
duction, but without statistical significance.
In the sub-analysis of the HORIZONS-AMI study, Prasad et al. 
showed that while the DBT is one of the predictors of microvascular 
injury (evaluated by the resolution of ST-segment elevation and 
myocardial blush at angiography), the total ischemic time (time of 
symptom onset until reperfusion) is more important. After 2 hours 
of total ischemia, patients with DBT < 90 minutes had a microvascu-
lar perfusion resolution rate similar to those with time ≥ 90 minutes. 
As the present patients had a mean total time of ischemia > 2 hours, 
this could possibly explain the negative result of the study, in terms 
of reduction of clinical outcomes in the group DBT < 90 minutes.22
In the present series, patients with DBT > 90 minutes, although 
older, with multivessel disease, and longer ischemic time, showed 
no difference in lenght of hospital stay. In accordance with Pepe et 
al., in the sample under analysis, the higher cost was related to the 
invasive treatment (68%), with a lower impact from daily hospital 
fees (10%) and drugs (25%).23
LCx treatment showed a higher cost than LAD and RCA treat-
ments, a finding that may be random, as the total number of patients 
in the sample was small. However, the LCx is an artery whose diag-
nostic difficulty is higher,24,25 and moreover, it has a higher incidence 
of post-infarction mechanical complications (mitral regurgita-
tion),26,27 which could also explain this finding.
This work aimed to call attention to the implications of costs 
when treating patients with acute myocardial infarction. Although 
health professionals are not trained to make decisions while taking 
costs into account, it is essential to remember that the resources, 
whether from the patient or the health insurance, are limited.
The major limitation of this study was probably the sample size 
(possible type 1 error). By increasing the sample, one could demons-
trate a statistical difference between the groups. Although it is a re-
trospective analysis, it would be unethical to carry out a prospective 
study to answer this question, considering the patient would be ex-
posed to risk in the group with DBT ≥ 90 minutes. The strong point of 
this study was the fact that doctors were not affected by the costs in 
decision-making, therefore reflecting daily clinical practice.
Conclusions
There was no difference in hospital costs when groups were divi-
ded according to the door-to-balloon time. Clinical outcomes were 
similar and a difference in costs was found for patients with the cir-
cumflex artery as the culprit vessel.
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